• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

对短短芽孢杆菌产生的重组霍乱毒素B亚单位作为黏膜佐剂的细胞因子反应。

Cytokine responses to recombinant cholera toxin B subunit produced by Bacillus brevis as a mucosal adjuvant.

作者信息

Maeyama J, Isaka M, Yasuda Y, Matano K, Kozuka S, Taniguchi T, Ohkuma K, Tochikubo K, Goto N

机构信息

Department of Safety Research on Biologics, National Institute of Infectious Diseases, Musashimurayama, Tokyo, Japan.

出版信息

Microbiol Immunol. 2001;45(2):111-7. doi: 10.1111/j.1348-0421.2001.tb01276.x.

DOI:10.1111/j.1348-0421.2001.tb01276.x
PMID:11293476
Abstract

We attempted to clarify the mechanism of the mucosal adjuvanticity of recombinant cholera toxin B subunit (rCTB), which is inherently uncontaminated with the holotoxin produced by Bacillus brevis and has a powerful mucosal adjuvant activity, on cytokine responses compared with that of cholera toxin (CT). rCTB had no ability to stimulate cyclic AMP formation in mouse peritoneal macrophages (Mphi). Cytokine production by non-immunized Mphi cultured with rCTB or CT and by the spleen cells of mice co-immunized intranasally with ovalbumin (OVA) and rCTB or CT was examined. rCTB alone did not induce interleukin (IL)-1alpha/beta or IL-6 production by Mphi, but combination of rCTB with lipopolysaccharide (LPS) enhanced both IL-1alpha/beta production. Conversely, CT plus LPS suppressed IL-1alpha/beta production more than LPS alone. Both rCTB and CT suppressed IL-12 secretion induced by interferon gamma (IFN gamma) plus LPS. IL-2, IL-4, IL-5, and IL-10 were secreted by mouse spleen cells restimulated with OVA after intranasal co-administration of OVA together with rCTB, and in response to CT, the same cytokines were secreted. The different effect of rCTB on Mphi from that of CT may mean a difference between the mechanisms of rCTB and CT during the early stage of an immune response.

摘要

我们试图阐明重组霍乱毒素B亚基(rCTB)的黏膜佐剂作用机制,rCTB天然不被短芽孢杆菌产生的全毒素污染,具有强大的黏膜佐剂活性,我们将其与霍乱毒素(CT)相比,研究其对细胞因子反应的影响。rCTB无法刺激小鼠腹腔巨噬细胞(Mphi)中环状AMP的形成。检测了用rCTB或CT培养的未免疫Mphi以及经鼻联合免疫卵清蛋白(OVA)与rCTB或CT的小鼠脾细胞产生细胞因子的情况。单独的rCTB不会诱导Mphi产生白细胞介素(IL)-1α/β或IL-6,但rCTB与脂多糖(LPS)联合使用可增强IL-1α/β的产生。相反,CT加LPS比单独的LPS更能抑制IL-1α/β的产生。rCTB和CT均抑制干扰素γ(IFNγ)加LPS诱导的IL-12分泌。经鼻联合给予OVA与rCTB后,用OVA再次刺激的小鼠脾细胞分泌IL-2、IL-4、IL-5和IL-10,对CT有反应时,也分泌相同的细胞因子。rCTB对Mphi的作用与CT不同,这可能意味着在免疫反应早期rCTB和CT的作用机制存在差异。

相似文献

1
Cytokine responses to recombinant cholera toxin B subunit produced by Bacillus brevis as a mucosal adjuvant.对短短芽孢杆菌产生的重组霍乱毒素B亚单位作为黏膜佐剂的细胞因子反应。
Microbiol Immunol. 2001;45(2):111-7. doi: 10.1111/j.1348-0421.2001.tb01276.x.
2
Safety evaluation of recombinant cholera toxin B subunit produced by Bacillus brevis as a mucosal adjuvant.短短芽孢杆菌产生的重组霍乱毒素B亚基作为黏膜佐剂的安全性评价
Vaccine. 2000 Apr 14;18(20):2164-71. doi: 10.1016/s0264-410x(99)00337-0.
3
Mucosal and systemic antibody responses against an acellular pertussis vaccine in mice after intranasal co-administration with recombinant cholera toxin B subunit as an adjuvant.鼻内联合使用重组霍乱毒素B亚单位作为佐剂后,小鼠针对无细胞百日咳疫苗的黏膜和全身抗体反应。
Vaccine. 2003 Mar 7;21(11-12):1165-73. doi: 10.1016/s0264-410x(02)00516-9.
4
Enhanced soluble production of cholera toxin B subunit in Escherichia coli by co-expression of SKP chaperones.通过共表达SKP伴侣蛋白增强霍乱毒素B亚单位在大肠杆菌中的可溶性表达。
Protein Expr Purif. 2017 Oct;138:1-6. doi: 10.1016/j.pep.2017.06.018. Epub 2017 Jun 30.
5
Mucosal immunization with purified flagellin from Salmonella induces systemic and mucosal immune responses in C3H/HeJ mice.用来自沙门氏菌的纯化鞭毛蛋白进行黏膜免疫可在C3H/HeJ小鼠中诱导全身和黏膜免疫反应。
Vaccine. 2004 Sep 9;22(27-28):3797-808. doi: 10.1016/j.vaccine.2003.12.035.
6
Recombinant cholera toxin B subunit is not an effective mucosal adjuvant for oral immunization of mice against Helicobacter felis.重组霍乱毒素B亚单位并非用于小鼠口服免疫抗猫幽门螺杆菌的有效黏膜佐剂。
Immunology. 1998 May;94(1):22-7. doi: 10.1046/j.1365-2567.1998.00482.x.
7
Mucosal immunization against hepatitis B virus by intranasal co-administration of recombinant hepatitis B surface antigen and recombinant cholera toxin B subunit as an adjuvant.通过鼻内联合给予重组乙型肝炎表面抗原和作为佐剂的重组霍乱毒素B亚单位对乙型肝炎病毒进行黏膜免疫。
Vaccine. 2001 Jan 8;19(11-12):1460-6. doi: 10.1016/s0264-410x(00)00348-0.
8
Effects of recombinant cholera toxin b subunit (rCTB) on cellular immune responses: enhancement of delayed-type hypersensitivity following intranasal co-administration of Mycobacterium bovis-BCG with rCTB.
Microbiol Immunol. 2004;48(6):457-63. doi: 10.1111/j.1348-0421.2004.tb03536.x.
9
Effects of recombinant cholera toxin B subunit on IL-1beta production by macrophages in vitro.
Microbiol Immunol. 2002;46(9):593-9. doi: 10.1111/j.1348-0421.2002.tb02740.x.
10
Recombinant cholera toxin B subunit (rCTB) as a mucosal adjuvant enhances induction of diphtheria and tetanus antitoxin antibodies in mice by intranasal administration with diphtheria-pertussis-tetanus (DPT) combination vaccine.重组霍乱毒素B亚单位(rCTB)作为一种黏膜佐剂,通过与白喉-百日咳-破伤风(DPT)联合疫苗经鼻内给药,增强小鼠对白喉和破伤风抗毒素抗体的诱导。
Vaccine. 2004 Aug 13;22(23-24):3061-8. doi: 10.1016/j.vaccine.2004.02.019.

引用本文的文献

1
Development of safe, effective and immunogenic vaccine candidate for diarrheagenic Escherichia coli main pathotypes in a mouse model.在小鼠模型中开发针对致泻性大肠杆菌主要致病型的安全、有效且具有免疫原性的候选疫苗。
BMC Res Notes. 2016 Feb 9;9:80. doi: 10.1186/s13104-016-1891-z.
2
Cholera toxin B induced activation of murine macrophages exposed to a fixed bacterial immunogen.霍乱毒素B诱导暴露于固定化细菌免疫原的小鼠巨噬细胞活化。
Ther Adv Vaccines. 2015 Sep;3(5-6):155-63. doi: 10.1177/2051013615613473.
3
CpG oligodeoxynucleotides as mucosal adjuvants.
作为黏膜佐剂的CpG寡脱氧核苷酸。
Hum Vaccin Immunother. 2015;11(3):755-60. doi: 10.1080/21645515.2014.1004033.